The Independent Market Observer

Will the China Coronavirus Strike Investments?

Posted by Brad McMillan, CFA®, CFP®

Find me on:

This entry was posted on Jan 24, 2020 2:19:42 PM

and tagged Commentary

Leave a comment

coronavirusOne of the potential disruptors of the generally positive economic news surfaced in the form of a viral outbreak in China last week. Known as the coronavirus, as of this morning, there were 895 cases in mainland China (mostly in the Wuhan area) and 26 deaths, for a mortality rate of less than 3 percent. There were also at least 20 other cases around the world, including 1 case here in the U.S. The comparison that is being made is to the last major new disease from China, SARS, in 2003.

Chinese cities shut down

This virus is a big deal, and all countries are taking it seriously. While the World Health Organization has not yet declared a global emergency, China has mobilized and has quarantined Wuhan and two other cities to prevent the spread of the disease. As a local business and transit hub, Wuhan has the potential to send any local infection around the world quickly, a situation that could be made exponentially worse by the mass travel associated with the Chinese Lunar New Year holiday. To get an idea of how serious the government response has been, imagine Chicago being shut down at Thanksgiving here in the U.S. The response this time has been much faster, and much more effective, than it was with SARS.

What does this outbreak mean for us here in the U.S.? We have two different sets of worries. As people, will the disease affect us or our loved ones directly? Second, what, if anything, will this mean for our investments?

The U.S. health risk

From a U.S. perspective, things seem to be under control. First, this new virus is a much less dangerous disease than was SARS. For SARS overall, there were more than 8,000 cases around the world and 775 deaths, for a mortality rate of more than 9 percent. The current virus, with a current mortality rate of 3 percent, is simply less dangerous.

Second, there are very few cases here in the U.S. (two reported as I write this). Further, surveillance is now in place to try to catch new patients coming in from the risk areas. Again, looking back at SARS, there ended up being just 27 cases here and no deaths. Nothing is certain, but the U.S. has excellent public health institutions for just this reason. The risk to our health is not quite zero, but probably pretty close. Again, the new disease does not seem to be nearly as fatal as SARS, and the response has been faster and more complete this time.

The investment risk

From an investment standpoint, the damage may be more substantial. But, again, it should not be that bad, especially here in the U.S.

In China, SARS hit growth hard for a short time, but then it passed quickly. Most of the damage came from consumers staying in and not spending, rather than from something fundamental. So, when the consumers came back out, growth resumed. We might see that dip in consumer spending again, and even worse this time, as the timing at the start of the Lunar New Year will certainly hit spending. More, consumer spending is now a larger part of the Chinese economy, so the hit might be worse. The South China Morning Post reports an estimate of a loss of between 0.5 percent and 1 percent of growth, off a 5.9 percent starting point. This drop would be material, but not catastrophic.

Looking back at SARS, there was essentially no effect on economic growth here in the U.S. While there was a sharp but short pullback in the stock market, it was not necessarily due to SARS alone. In any case, the market bounced back quickly. Over the course of a year, SARS was a nonissue for U.S. investors. With the more favorable conditions in place this time, even if this new disease proves to be much worse than it looks at the moment, here in the U.S. the damage will be limited—and should pass quickly.

Pay attention, don’t worry

That’s not to say the disease will not get worse. It might, and we need to keep an eye on the situation. Even if it does, however, the fact that the problem is now well known should keep the overall impact from being something we need to worry about over the long term.

In the end, the coronavirus is just one more item on the list of things we should pay attention to—but it is not something I am worried about at the moment.


Subscribe via Email

Crash-Test Investing

Hot Topics



New Call-to-action

Conversations

Archives

see all

Subscribe


Disclosure

The information on this website is intended for informational/educational purposes only and should not be construed as investment advice, a solicitation, or a recommendation to buy or sell any security or investment product. Please contact your financial professional for more information specific to your situation.

Certain sections of this commentary contain forward-looking statements that are based on our reasonable expectations, estimates, projections, and assumptions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Past performance is not indicative of future results. Diversification does not assure a profit or protect against loss in declining markets.

The S&P 500 Index is a broad-based measurement of changes in stock market conditions based on the average performance of 500 widely held common stocks. All indices are unmanaged and investors cannot invest directly in an index.

The MSCI EAFE (Europe, Australia, Far East) Index is a free float‐adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. The MSCI EAFE Index consists of 21 developed market country indices.

One basis point (bp) is equal to 1/100th of 1 percent, or 0.01 percent.

The VIX (CBOE Volatility Index) measures the market’s expectation of 30-day volatility across a wide range of S&P 500 options.

The forward price-to-earnings (P/E) ratio divides the current share price of the index by its estimated future earnings.

Third-party links are provided to you as a courtesy. We make no representation as to the completeness or accuracy of information provided on these websites. Information on such sites, including third-party links contained within, should not be construed as an endorsement or adoption by Commonwealth of any kind. You should consult with a financial advisor regarding your specific situation.

Member FINRASIPC

Please review our Terms of Use

Commonwealth Financial Network®